ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Earnings Call

Shalby Earnings Call: Key Takeaways

Shalby Limited delivered Q4 FY26 consolidated revenue growth of 9.4% YoY. Strategy focuses on diversifying specialties beyond arthroplasty and expanding the MedTech implant business.

Highlights
Revenue growth4.8% YoY for FY26; 9.4% YoY for Q4 FY26.
MarginsConsolidated EBITDA margin steady at 14.5% for FY26.
Demand visibilityStrong surgery counts in Oncology and Nephro-Urology segments.
Management confidenceHigh in 'Zero Technique' and multi-specialty diversification.

Growth

FY26 Consolidated Revenue reached ₹11,682 mn (up 4.8% YoY); PAT surged 1706% YoY to ₹347 mn due to tax regime adoption.

Outlook

Targeting 2200+ beds across 10 cities; focusing on doubling ROCE through operational leverage and asset-light O&M models.

Risks

International business (Delhi-NCR) reported EBITDA losses; hospital occupancy remains relatively low at 48%.

Source

Earnings Call filed with BSE, NSE: SHALBY. Summary written with AI assistance from the document.

Read the document ↗

Shalby Ltd: key numbers

Share price
₹126.99
Market cap
₹1,372 Cr
Revenue (annual)
₹1,141 Cr
Net profit (annual)
₹37.39 Cr
P/E (TTM)
35.0×Sector 54.5×
Promoter holding
74.33%+0.00% QoQ
FII holding
4.65%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Shalby Ltd

All →